TUDOR INVESTMENT CORP ET AL

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 923093 STAMFORD, CT

Back to TAK Full portfolio

Position in TAK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,605,388

+$1,605,388 QoQ

Shares Held

100,149

Ownership

0.003%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#79

of 375 holders

Holding Since

Mar 2023

5 quarters on record

Voting authority Sole 50% Shared 50% None 0%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Derivatives in TAK

reported options exposure · as of Sep 30, 2025

CallValue

$452,376

CallShares

30,900

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $64,629,641 across 19 Drug Manufacturers - Specialty & Generic names. TAK ranks #8 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	490,000	$16,601,200
2	ZTS	Zoetis Inc.	208,246	$14,964,557
3	HLN	Haleon plc	762,877	$7,117,642
4	UTHR	UNITED THERAPEUTICS Corp	12,667	$6,863,360
5	ELAN	Elanco Animal Health Inc	256,108	$6,302,817
6	HIMS	Hims & Hers Health, Inc.	128,796	$4,465,357
7	BCRX	Biocryst Pharmaceuticals Inc	195,128	$1,951,280
8	TAK	Takeda Pharmaceutical Co Ltd This page	100,149	$1,605,388

All Filings in TAK

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,605,388	100,149	+434.9%	Shares	Defined	2026-08-14
2025-09-30	$452,376	30,900	—	Call	Defined	2025-12-09
2023-12-31	$267,191	18,724	-89.0%	Shares	Defined	2024-02-14
2023-06-30	$2,683,550	170,818	+54.0%	Shares	Defined	2023-08-14
2023-03-31	$1,828,307	110,941	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.